RxE2

RxE2 is a San Diego-based company founded in 2016 that is pioneering a community-based clinical trial model using independent pharmacies as research sites. The company addresses the critical industry challenges of patient recruitment delays, lack of diversity, and site fatigue by tapping into the extensive reach and high trust of local pharmacists. Its platform provides sponsors with decentralized access to a broad patient population, aiming to make trials more efficient, accessible, and representative. This approach targets the core '80/20 problem' where most research occurs in academic centers while most healthcare is delivered in the community.

Proprietary platform 'habitu' that connects trial sponsors with a network of community pharmacies, facilitating site management, patient recruitment, data capture, and clinical supplies logistics for decentralized trials.

Competes within the broader decentralized clinical trial (DCT) ecosystem against telemedicine providers, in-home nursing services, and dedicated mobile or pop-up research sites. Differentiates by leveraging the high-trust, high-frequency access points of existing community pharmacy infrastructure.